583 related articles for article (PubMed ID: 12647423)
1. [Long-term lithium prophylaxis in the bipolar affective disorder].
Suwalska A; Chłopocka-Woźniak M; Rybakowski J
Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
[TBL] [Abstract][Full Text] [Related]
2. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
3. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Amsterdam JD; Shults J
J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
[TBL] [Abstract][Full Text] [Related]
4. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
[TBL] [Abstract][Full Text] [Related]
5. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
6. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
[TBL] [Abstract][Full Text] [Related]
7. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder.
Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Kunugi H; Koyama T
Psychiatr Genet; 2006 Apr; 16(2):49-50. PubMed ID: 16538178
[TBL] [Abstract][Full Text] [Related]
8. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
Sugawara H; Sakamoto K; Harada T; Ishigooka J
J Affect Disord; 2010 Sep; 125(1-3):165-8. PubMed ID: 20089312
[TBL] [Abstract][Full Text] [Related]
9. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
[TBL] [Abstract][Full Text] [Related]
10. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.
Gonzalez-Pinto A; Mosquera F; Alonso M; López P; Ramírez F; Vieta E; Baldessarini RJ
Bipolar Disord; 2006 Oct; 8(5 Pt 2):618-24. PubMed ID: 17042834
[TBL] [Abstract][Full Text] [Related]
11. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
[TBL] [Abstract][Full Text] [Related]
12. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
[TBL] [Abstract][Full Text] [Related]
14. Trichotillomania: response to lithium in a person with comorbid bipolar disorder.
Berk M; McKenzie H; Dodd S
Hum Psychopharmacol; 2003 Oct; 18(7):576-7. PubMed ID: 14533143
[No Abstract] [Full Text] [Related]
15. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
[TBL] [Abstract][Full Text] [Related]
16. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
Yazici O; Kora K; Polat A; Saylan M
J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
[TBL] [Abstract][Full Text] [Related]
17. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
18. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
[TBL] [Abstract][Full Text] [Related]
19. [Bipolar disorder. Follow-up of lithium therapy in a clinic].
Agulló Hernández MD; Sanz Osorio MT; Barbarà Berdaguer M; Vallès i Callol V; Garolera Freixa M; Delgado Cruz L; Alberni i Coderch J
Rev Enferm; 2000 Mar; 23(3):177-80. PubMed ID: 10797777
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
Licht RW; Vestergaard P; Brodersen A
Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
